SCHEMBL20127469

SCHEMBL20127469

c1ccc2c(c1)ccc1ccc(-c3c4ccccc4c(-c4ccc5c(ccc6oc7ccccc7c65)c4)c4ccccc34)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HIF1A Q16665 1/20 0.42
CYP1B1 Q16678 1/20 0.42
ABCG2 Q9UNQ0 6/20 0.40
PAX8 Q06710 2/20 0.40
AHR P35869 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127474 0.97 TDP1 (0.50) TDP1L3MBTL1HSD17B10ALDH1A1HIF1A
SCHEMBL20127296 0.94 TDP1 (0.43) TDP1L3MBTL1HSD17B10ALDH1A1HIF1A
SCHEMBL20127471 0.92 TDP1 (0.46) TDP1L3MBTL1HSD17B10ALDH1A1HIF1A
SCHEMBL20127334 0.91 TDP1 (0.46) TDP1L3MBTL1ALDH1A1CYP1B1ABCG2
SCHEMBL20412636 0.91 TDP1 (0.43) TDP1L3MBTL1HSD17B10ALDH1A1HIF1A
SCHEMBL20127476 0.91 TDP1 (0.43) TDP1L3MBTL1HSD17B10ALDH1A1ABCG2
SCHEMBL20127488 0.91 MAPT (0.44) TDP1L3MBTL1ALDH1A1ABCG2PAX8
SCHEMBL20412637 0.91 TDP1 (0.43) TDP1L3MBTL1HSD17B10ALDH1A1HIF1A
SCHEMBL20127294 0.91 ABCG2 (0.44) TDP1L3MBTL1HSD17B10ALDH1A1HIF1A
SCHEMBL20127500 0.90 TDP1 (0.45) TDP1L3MBTL1CYP1B1ABCG2PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 TDP1 3427/4885L3MBTL1 1670/4885HSD17B10 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.